论文信息 - The first case report of fatal acute pulmonary dysfunction in a systemic sclerosis patient treated with rituximab

The first case report of fatal acute pulmonary dysfunction in a systemic sclerosis patient treated with rituximab

Systemic sclerosis (SSc) is a multisystem disorder that affects numerous organs. SSc-associated interstitial lung disease (SSc-ILD) is one of the main causes of death in SSc patients. Scleroderma r...

[1] Nilanjana Bose,et al. Scleroderma renal crisis. , 2015, Seminars in arthritis and rheumatism.

[2] D. Huscher,et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group , 2014, Annals of the rheumatic diseases.

[3] W. Leonard,et al. Regulatory B Cells Control T Cell Autoimmunity Through IL-21-Dependent Cognate Interactions , 2012, Nature.

[4] E. Chilvers,et al. Non-infectious pulmonary toxicity of rituximab: a systematic review. , 2012, Rheumatology.

[5] D. Elewaut,et al. Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study , 2008, Annals of the rheumatic diseases.

[6] M. Aubry,et al. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. , 2007, Chest.

[7] Y. Hayami,et al. Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature , 2007, Modern rheumatology.

[8] M. Perelman,et al. Pulmonary-renal syndrome in systemic sclerosis. , 2001, Seminars in arthritis and rheumatism.

[9] C. Putman,et al. Pulmonary renal syndromes--a review. , 1980, The Yale journal of biology and medicine.